US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Purdue Pharma L.P.

Track this case

Case overview

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

  1. April 16, 2020

    Purdue Says Ch. 11 Stay Can't Be Lifted For NY Opioid Trial

    Purdue Pharma LP on Wednesday asked a New York bankruptcy judge to reject a bid by pharmaceutical companies and pharmacies who are co-defendants in the New York opioid trial to include the OxyContin maker on the verdict form, saying that it could upset negotiations for a global settlement.

  2. April 08, 2020

    NY AG Seeks Additional Sackler Family Financial Info

    The New York attorney general on Tuesday asked a bankruptcy court to resume discovery into the finances of the Sackler family, who owns Purdue Pharma LP, saying that her office has already unearthed important information about money transfers the family has made.

  3. March 18, 2020

    Purdue, Sacklers Keep Opioid Suit Shield For 6 More Months

    A New York bankruptcy judge agreed on Wednesday to extend an injunction halting opioid lawsuits against Purdue Pharma LP for a further 180 days, dismissing arguments that the stay should not extend to the family that owns the drugmaker.

  4. March 16, 2020

    Sacklers Say Major Purdue Deal Hinges On Longer Ch. 11 Stay

    The family who owns opioid maker Purdue Pharma LP asked a New York bankruptcy court Monday to extend a stay of legal action against them, arguing renewed litigation could sink a settlement that would let the company's assets be used to mitigate the national opioid crisis.

  5. March 05, 2020

    Purdue Wants Ch. 11 To Hold Opioid Cases At Bay Longer

    Bankrupt opioid maker Purdue Pharma LP asked a New York judge late Wednesday to extend a preliminary injunction enacted in its Chapter 11 case that paused thousands of legal actions against the company for its role in the national opioid crisis.

  6. March 02, 2020

    Mediators To Form Plan For Purdue Ch. 11 Claims Distribution

    A New York bankruptcy judge on Monday approved an order setting up mediation between government and private parties with claims in the Purdue Pharma Chapter 11 case to work out how to divide up the estate's billions of dollars in assets.

  7. February 21, 2020

    Purdue Picks Ex-USDA Head As Monitor In Bankruptcy

    Purdue Pharma LP announced on Friday that it has tapped former U.S. Secretary of Agriculture Tom Vilsack to monitor compliance with an injunction in the OxyContin maker's ongoing Chapter 11 bankruptcy proceedings.

  8. February 12, 2020

    Purdue Wants To Make New Opioid Overdose Drug

    Purdue Pharma LP is seeking bankruptcy court approval to begin developing an injectable treatment to reverse overdoses of fentanyl and other opioids, telling the court that time is of the essence in addressing a public health crisis that many have alleged it helped create.

  9. January 24, 2020

    Bankruptcy Judge OKs $1.3M Bonus For Purdue CEO

    A New York bankruptcy judge ended a monthslong dispute over pay for Purdue Pharmaceutical executives Friday, saying a $1.3 million bonus for the company's CEO is reasonable for the industry.

  10. January 21, 2020

    Purdue, Creditors Ask To Keep Stay On Insurance Arbitration

    Purdue Pharma and its unsecured creditors are asking a New York bankruptcy judge to deny an insurer's request to allow arbitration over how much product liability coverage it owes the drugmaker to proceed, saying it could severely disrupt Purdue's Chapter 11 case.